ArticlePublisher preview available

Multiple aggregated yellow‐white ( MAY ) globules, a dermoscopic sign to be considered in the presurgical evaluation in Mohs surgery

Wiley
Dermatologic Therapy
Authors:
To read the full-text of this research, you can request a copy directly from the authors.
LETTER
Multiple aggregated yellow-white globules, a dermoscopic sign
to be considered in the presurgical evaluation in Mohs surgery
Dear Editor,
High-risk basal cell carcinomas (BCCs) are mostly treated with Mohs
micrographic surgery (MMS) due to lower recurrence rate when
treated with this treatment modality.
1
Dermoscopy has a high diag-
nostic accuracy for the diagnosis of BCC and recently, multiple aggre-
gated yellow white globules (MAY) were described as a dermoscopic
sign associated with high-risk BCCs.
2
However, MAY's role in margin
delineation of MMS has not been studied.
A 55-year-old male was referred for an asymptomatic, 18-month
lesion on the nasal sidewall, adjacent to the internal canthus. On phys-
ical examination, he presented with an 8 8-mm ill-defined pearly
papule. On dermoscopy, the lesion showed arborizing telangiectasia,
blue-gray globules, and in-focus dots (Figure 1A,B). A diagnosis of
high-risk BCC was performed, and MMS was suggested given the
high-risk location. When defining the initial surgical margins,
peripheral areas displaying a multitude of MAY globules were noted,
and therefore, they were included on the first stage margin marking
(Figure 1B,C). Tumor diameter increased from 8 8mm to
11 9 mm when considering the peripheral areas with MAY globules.
Despite the above, all peripheral margins were involved on frozen sec-
tions with BCC, micronodular subtype, on first stage (Figure 1E,F). A
whole rim of peripheral and deep margins was subsequently taken.
Margins were clear after a second stage, resulting on an 18 15 mm
surgical defect (Figure 1D,G). A full thickness skin graft was used to
close the defect with excellent cosmetic results.
MAY globules were recently described as new diagnostic criteria
for the diagnosis of BCC correlating with calcium deposits on histo-
pathology, as we see in our case (Figure 1E,F). Besides BCC diagno-
sis, they were also associated with high-risk BCC histologic subtypes
(e.g., morpheaform, micronodular, infiltrative).
2
Herein, we have
FIGURE 1 Basal cell carcinoma (BCC), micronodular, on right lateral side wall of nose adjacent to the internal canthus. (A) Clinical features
and initial demarcation prior to dermoscopy (dashed light blue line). (B) Dermoscopy image showing blue-gray globules, arborizing telangiectasia,
and MAY globules on the periphery (red arrows). Dermoscopic delineation is shown with dashed black lines (Polarized image, original
magnification 10). (C) Final demarcation of intended first stage after including MAY globules. (D) Final defect after 2 stages. (E) Histopathology,
Mohs micrographic surgery (MMS) first stage, en face view, showing tumor islands of micronodular BCC with calcium deposits (black rectangle)
on deep and lateral margins (H&E, 2). (F) Higher magnification of the dystrophic calcification in tumor nodule (center of the image) (H&E, 20).
(G) Second MMS stage, en face view, with no further evidence of tumor (H&E, 2)
Received: 2 January 2022 Revised: 13 January 2022 Accepted: 23 January 2022
DOI: 10.1111/dth.15333
Dermatologic Therapy. 2022;35:e15333. wileyonlinelibrary.com/journal/dth © 2022 Wiley Periodicals LLC. 1of2
https://doi.org/10.1111/dth.15333
... Fourteen full-text articles were assessed for eligibility. Among these, 4 were excluded (case reports and noncomparative studies) [16][17][18][19]. Three research letters were excluded [11,20,21]. ...
Article
Full-text available
Introduction: Several studies investigated the use of dermoscopy in the delineation of basal cell carcinoma (BCC) for Mohs micrographic surgery (MMS) with conflicting results. Objectives: The purpose of this systematic review with meta-analysis was to evaluate the effectiveness of the use of dermoscopy-guided MMS in the treatment of BCC. Methods: We included all comparative studies. Cases of BCC treated using dermoscopy-guided MMS (or slow MMS) were compared to those treated with curettage-guided MMS or "standard" MMS. Results: A total of 6 studies including 508 BCCs were reviewed. There was no statistically significant difference in the proportion of total margin clearance on the first MMS stage between BCCs removed using dermoscopy-guided MMS and those that had curettage or visual inspection. However, lateral margin involvement was significantly lower in BCCs that had dermoscopy-guided MMS. Conclusions: Dermoscopy allows visualization of structures up to 1mm into the dermis. Therefore, it is rational to use it for lateral margin evaluation. Currently, there are two comparative studies showing the efficacy of dermoscopy for lateral margin evaluation during MMS. Future studies are required to develop an evidence-based recommendation regarding the utility of dermoscopy in MMS.
Article
Full-text available
There is a need for adjuvant imaging techniques that would allow reducing the number of slow Mohs stages. This study aimed to evaluate the use of dermoscopy in the demarcation of basal cell carcinoma (BCC) surgical margins for slow Mohs surgery. This was a retrospective study over 3 years (2016‐2019), including patients with BCC excised using slow Mohs surgery. On the basis of the treatment received, the patients were divided into 2 groups: group 1 (28 BCC) and group 2 (26 BCC). In group 2, BCC margins were demarcated using dermoscopy. A total of 54 patients were enrolled in the study. The number of positive lateral margins was significantly lower in the group where BCC margins were demarcated using dermoscopy (19% vs 53%, P = 0.012). In this group, the number of Mohs stages needed to achieve complete clearance was significantly lower. However, the mean interval between the first Mohs excision and Mohs clearance wasn't significantly different between the 2 groups (9 ± 4 vs 12 ± 7 days). Preoperative dermoscopy is useful for reducing the number of positive lateral margins and the number of slow Mohs stages in treating BCC especially pigmented tumors. This article is protected by copyright. All rights reserved.
Article
Full-text available
Importance Basal cell carcinoma (BCC) is the most common skin cancer. Dermoscopic imaging has improved diagnostic accuracy; however, diagnosis of nonpigmented BCC remains limited to arborizing vessels, ulceration, and shiny white structures. Objective To assess multiple aggregated yellow-white (MAY) globules as a diagnostic feature for BCC. Design, Setting, and Participants In this retrospective, single-center, case-control study, nonpigmented skin tumors, determined clinically, were identified from a database of lesions consecutively biopsied during a 7-year period (January 1, 2009, to December 31, 2015). A subset of tumors was prospectively diagnosed, and reflectance confocal microscopy, optical coherence tomography, and histopathologic correlation were performed. Data analysis was conducted from July 1 to September 31, 2019. Exposures Investigators evaluated for the presence or absence of known dermoscopic criteria. MAY globules were defined as aggregated, white-yellow structures visualized in polarized and nonpolarized light. Main Outcomes and Measures The primary outcome was the diagnostic accuracy of MAY globules for the diagnosis of BCC. Secondary objectives included the association with BCC location and subtype. Interrater agreement was estimated. Results A total of 656 nonpigmented lesions from 643 patients (mean [SD] age, 63.1 [14.9] years; 381 [58.1%] male) were included. In all, 194 lesions (29.6%) were located on the head and neck. A total of 291 (44.4%) were BCCs. MAY globules were seen in 61 of 291 BCC cases (21.0%) and in 3 of 365 other diagnoses (0.8%) (P < .001). The odds ratio for diagnosis of BCC was 32.0 (96% CI, 9.9-103.2). The presence of MAY globules was associated with a diagnosis of histologic high-risk BCC (odds ratio, 6.5; 95% CI, 3.1-14.3). The structure was never seen in cases of superficial BCCs. Conclusions and Relevance The findings suggest that MAY globules may have utility as a new BCC dermoscopic criterion with a high specificity. MAY globules were negatively associated with superficial BCC and positively associated with deeper-seated, histologic, higher-grade tumor subtypes.
Article
Background: Mohs micrographic surgery (MMS) in cases where the tumor margin is poorly defined to the naked eye can lead to the need to take an increased number of Mohs stages. Objective: To evaluate the usefulness of dermoscopy in determining MMS surgical margins of BCCs with a history of ablative laser treatment. Methods: Patients were randomly allocated to naked eye (n = 69) or dermoscopy (n = 64) groups by the surgical margin detection method. Surgical outcomes of 133 post-laser BCC patients treated with MMS were analyzed. Results: The lateral margin involvement rate at the first MMS stage was significantly lower in the dermoscopy group than in the naked eye group (4.7% vs. 29.0%; P<.001). However, the deep margin involvement rate at the first and mean MMS stages were not significantly different between the groups. The ablative laser treatment duration correlated to the number of MMS stages (P=.026). Conclusion: The results demonstrated that lateral margin was mostly controlled within the first MMS stage with dermoscopy. Dermatosurgeons could focus on the deep margin after the first MMS stage; thus, the performance of MMS could be improved with dermoscopic assistance in post-laser BCC patients.
Article
Dermoscopy prior to Mohs Micrographic surgery does not improve tumour margin assessment for basal cell carcinoma of the head and neck and lead to fewer Mohs stages Mohs micrographic surgery (MMS) is a time consuming and expensive gold standard treatment for difficult to treat basal cell carcinoma (BCC). One factor that contributes significantly to the expense and duration is the number of stages required to obtain clear excision margins. This article is protected by copyright. All rights reserved.